DNA-dependent protein kinase (DNA-PK) plays a critical role in repairing damaged DNA. Inhibitors of DNA-PK hold immense promise in cancer therapy. By blocking DNA repair, they make cancer cells more vulnerable to other treatments, such as radiation and chemotherapy, which target DNA damage.
